-+ 0.00%
-+ 0.00%
-+ 0.00%

Oncopeptides' Government-Backed Glioblastoma Project Meets All Objectives

PUBT·11/12/2026 14:21:30
Listen to the news
Oncopeptides' Government-Backed Glioblastoma Project Meets All Objectives
  • Oncopeptides' three-year, Eurostars-3/Vinnova-backed GLIOPEP project met all objectives, supporting its strategy to advance glioblastoma treatments toward clinical development.
  • Previously disclosed funding totaled approximately SEK 3.3 million, matched by an equivalent company co-funding commitment.
  • Consortium partners included Uppsala University, Spain's Xenopat and the Netherlands' Crown Bioscience.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncopeptides AB published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.